BioNTech expects UK cancer vaccine trials to start this year

Clinical trials of BioNTech’s cancer vaccines are due to begin in the UK this year, marking a major step towards their eventual sale on the open market, Ugur Sahin, a top executive at the German company, told Der Spiegel magazine.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner